Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Matson

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Scientific American|July 12, 2012
Nobel pursuits: The tools of science have changed since the golden age of physics, but many of the same questions remainJohn Matson, Ferris Jabr
Chemical Communications (Cambridge, England)|January 3, 2020
Elastase-triggered H<sub>2</sub>S delivery from polymer hydrogelsMingjun Zhou, Yun Qian, Yumeng Zhu, et al.
Polymers|November 4, 2020
Novel Electrospun Pullulan Fibers Incorporating Hydroxypropyl-β-Cyclodextrin: Morphology and Relation with Rheological PropertiesDeepak Poudel, Sarah Swilley-Sanchez, Sean O'keefe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 28, 2019
Metabolism and Disposition of Volanesorsen, a 2'-<i>O</i>-(2 methoxyethyl) Antisense Oligonucleotide, Across SpeciesNoah Post, Rosie Yu, Sarah Greenlee, et al.
Biochemical Pharmacology|April 28, 2009
Effect of dose and plasma concentration on liver uptake and pharmacologic activity of a 2'-methoxyethyl modified chimeric antisense oligonucleotide targeting PTENRichard S Geary, Ed Wancewicz, John Matson, et al.
Journal of Pharmaceutical Sciences|December 4, 2003
Tissue disposition of 2'-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeysRosie Z Yu, Richard S Geary, David K Monteith, et al.
Scientific American|June 5, 2010
12 events that will change everythingCharles Q Choi, George Musser, John Matson, et al.
Nucleic Acid Therapeutics|May 4, 2016
Effects of Repeated Complement Activation Associated with Chronic Treatment of Cynomolgus Monkeys with 2'-O-Methoxyethyl Modified Antisense OligonucleotideLijiang Shen, Jeffrey A Engelhardt, Gene Hung, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2003
Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across speciesRichard S Geary, Rosie Z Yu, Tanya Watanabe, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2018
Reducing dynamin 2 (DNM2) rescues <i>DNM2</i>-related dominant centronuclear myopathySuzie Buono, Jacob A Ross, Hichem Tasfaout, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Scientific American|July 12, 2012
Nobel pursuits: The tools of science have changed since the golden age of physics, but many of the same questions remainJohn Matson, Ferris Jabr
Chemical Communications (Cambridge, England)|January 3, 2020
Elastase-triggered H<sub>2</sub>S delivery from polymer hydrogelsMingjun Zhou, Yun Qian, Yumeng Zhu, et al.
Polymers|November 4, 2020
Novel Electrospun Pullulan Fibers Incorporating Hydroxypropyl-β-Cyclodextrin: Morphology and Relation with Rheological PropertiesDeepak Poudel, Sarah Swilley-Sanchez, Sean O'keefe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 28, 2019
Metabolism and Disposition of Volanesorsen, a 2'-<i>O</i>-(2 methoxyethyl) Antisense Oligonucleotide, Across SpeciesNoah Post, Rosie Yu, Sarah Greenlee, et al.
Biochemical Pharmacology|April 28, 2009
Effect of dose and plasma concentration on liver uptake and pharmacologic activity of a 2'-methoxyethyl modified chimeric antisense oligonucleotide targeting PTENRichard S Geary, Ed Wancewicz, John Matson, et al.
Journal of Pharmaceutical Sciences|December 4, 2003
Tissue disposition of 2'-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeysRosie Z Yu, Richard S Geary, David K Monteith, et al.
Scientific American|June 5, 2010
12 events that will change everythingCharles Q Choi, George Musser, John Matson, et al.
Nucleic Acid Therapeutics|May 4, 2016
Effects of Repeated Complement Activation Associated with Chronic Treatment of Cynomolgus Monkeys with 2'-O-Methoxyethyl Modified Antisense OligonucleotideLijiang Shen, Jeffrey A Engelhardt, Gene Hung, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2003
Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across speciesRichard S Geary, Rosie Z Yu, Tanya Watanabe, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2018
Reducing dynamin 2 (DNM2) rescues <i>DNM2</i>-related dominant centronuclear myopathySuzie Buono, Jacob A Ross, Hichem Tasfaout, et al.
Pageof 6